Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.
19

New US Performance Data Demonstrates Bausch + Lomb ULTRA® Contact Lenses are #1 Brand Patients Are Switching To Most Often


FOR RELEASE THURSDAY, MARCH 19, 2015

BRIDGEWATER, NJ — Bausch + Lomb, a leading global eye health company, celebrates the one-year anniversary of the roll-out of Bausch + Lomb ULTRA® contact lenses with the release of new U.S. brand performance data from the fourth quarter. In the data, 95 percent of patients agree, Bausch + Lomb contact lenses provide exceptional clarity and comfort, helping to make the lens the top competitive refit brand in the United States.1,2


Bausch + Lomb ULTRA contact lenses are a significant advancement in contact lens technology and today’s new data helps to further demonstrate the importance of this innovative achievement for eye care practitioners and their patients,” said Mark McKenna, vice president and general manager, U.S. Lens division, Bausch + Lomb. “Backed by seven years of scientific research and development, it is very rewarding to see such remarkable real-life feedback and experiences from Bausch + Lomb ULTRA contact lens patients. We look forward to providing this tremendous lens wearing experience for even more patients across the country this year.”

The nationwide study was conducted to evaluate Bausch + Lomb ULTRA among patients wearing other leading contact lenses.1 Of the patients who tried Bausch + Lomb ULTRA contact lenses:

  • Ninety-two percent of patients agreed that Bausch + Lomb ULTRA contact lenses are as comfortable at the end of the day as they are at the beginning, and;
  • Ninety-five percent of patients agreed that Bausch + Lomb ULTRA contact lenses provide exceptional clarity and comfort.

“Having extensive experience with Bausch + Lomb ULTRA contact lenses for the past year, I am extremely pleased with the results and feedback I’m seeing with my patients who are wearing this lens,” said Benjamin Gaddie, OD, FAAO. “It is no surprise to also see how well this lens is being received across the country due to the combination of excellent oxygen transmission, low modulus, comfortable edge profiles and the outstanding vision delivered by Bausch + Lomb’s aspheric optics. I’m proud to offer my patients an advancement that provides excellent comfort throughout the day to support their busy lifestyles.” 

Bausch + Lomb ULTRA contact lenses with MoistureSeal® technology combines a breakthrough material with new manufacturing processes to produce a contact lens that breaks the cycle of discomfort for superior comfort and vision all day among the leading silicone hydrogel lenses.3 This results in a lens that maintains 95 percent of its moisture for a full 16 hours.4

 

For more information on Bausch + Lomb ULTRA contact lenses, eye care practitioners can visit www.blultra.com

About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing, and restoring people’s eyesight. Our core businesses include ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. We develop, manufacture and market one of the most comprehensive product portfolios in our industry, which are available in more than 100 countries. 


References
1 Bausch + Lomb ULTRA National Survey Results, 2014.

2. Independent third party research, 2014.

3. Results from a 22-investigator, multi-site study of Bausch + Lomb ULTRA® contact lenses with MoistureSeal® technology, on 327 current silicone hydrogel lens wearers. After 7 days of wear, subjects completed an online survey. Subjects rated performance across a range of attributes. Preference comparisons represent only those subjects expressing a preference. Ratio is based on the average across the silicone hydrogel lenses represented in the study.
4. Schafer, J. and P. China. “16 hour, Bilateral, Dispensing Clinical Evaluation.”  R&D Clinical Report, 2013.

Bausch + Lomb ULTRA and MoistureSeal are trademarks of Bausch & Lomb Incorporated or its affiliates.
© 2015 Bausch & Lomb Incorporated



News Media Contacts:

 

Kristy Marks
Public Relations Product Manager, Bausch + Lomb

(585) 338-8095 or kristy.marks@bausch.com  

 

US/ZUS/15/0045

Actions: E-mail | Permalink |